JB Chemicals & Pharmaceuticals Limited
2,548words
0turns
0analyst exchanges
0executives
Key numbers — 31 extracted
rs,
ironment. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, financial condition, performance or achievements of the Company
70%
stent track record across multiple businesses 5 Brands among top 300 brands, contributing over 70% of domestic formulations revenues 40+ Regulated/semi-regulated markets of presence through dir
21%
Top 5 Global manufacturer of medicated/herbal lozenges representing a substantial opportunity 21% Growth in chronic therapies* in the domestic formulations business #2,100+ Strong India field
42%
cused segmentation 7 Multi-dosage formulation plants with key global approvals/ compliances **42% ROCE with strong cash position and consistent cash flow generation * CAGR over FY17-FY21 # Incl
27.4%
Mutual Fund Investments) 4 Revenue (INR cr) PAT (INR cr) EBITDA Margin (%) ROE (%) ROCE (%) 27.4% 18.6% 21.3% 1,643 1,775 2,043 15.4% 1,413 139 194 272 449 FY18 FY19 FY20 FY21 Finan
18.6%
Fund Investments) 4 Revenue (INR cr) PAT (INR cr) EBITDA Margin (%) ROE (%) ROCE (%) 27.4% 18.6% 21.3% 1,643 1,775 2,043 15.4% 1,413 139 194 272 449 FY18 FY19 FY20 FY21 Financial Ye
21.3%
nvestments) 4 Revenue (INR cr) PAT (INR cr) EBITDA Margin (%) ROE (%) ROCE (%) 27.4% 18.6% 21.3% 1,643 1,775 2,043 15.4% 1,413 139 194 272 449 FY18 FY19 FY20 FY21 Financial Year ends
15.4%
cr) PAT (INR cr) EBITDA Margin (%) ROE (%) ROCE (%) 27.4% 18.6% 21.3% 1,643 1,775 2,043 15.4% 1,413 139 194 272 449 FY18 FY19 FY20 FY21 Financial Year ends on 31st March 42% 25% 29
25%
15.4% 1,413 139 194 272 449 FY18 FY19 FY20 FY21 Financial Year ends on 31st March 42% 25% 29% 19% 24% 13% FY19 FY20 FY21 5 15% 10% FY18 FY21 224 86 24 Business-wise Revenue
29%
4% 1,413 139 194 272 449 FY18 FY19 FY20 FY21 Financial Year ends on 31st March 42% 25% 29% 19% 24% 13% FY19 FY20 FY21 5 15% 10% FY18 FY21 224 86 24 Business-wise Revenue (INR
19%
,413 139 194 272 449 FY18 FY19 FY20 FY21 Financial Year ends on 31st March 42% 25% 29% 19% 24% 13% FY19 FY20 FY21 5 15% 10% FY18 FY21 224 86 24 Business-wise Revenue (INR crore
24%
139 194 272 449 FY18 FY19 FY20 FY21 Financial Year ends on 31st March 42% 25% 29% 19% 24% 13% FY19 FY20 FY21 5 15% 10% FY18 FY21 224 86 24 Business-wise Revenue (INR crore) H1
Advertisement